AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Matthew Jones

Matthew Jones

Takeda Pharmaceutical Company Limited - Osaka / Japan
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4448811
武田薬品工業株式会社
person_outline Matthew Jones's MOST POPULAR ARTICLES
1-) Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit Biochemical Journal 430 (3), 461-476, 2010
2-) Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea Cancer chemotherapy and pharmacology 68 (5), 1145-1154, 2011
3-) Optimization of a series of dipeptides with a P3 threonine residue as non-covalent inhibitors of the chymotrypsin-like activity of the human 20S proteasome Bioorganic & medicinal chemistry letters 20 (22), 6581-6586, 2010
4-) Synthesis of 3-amino-1, 2, 4-benzothiadi-azine 1, 1-dioxides via a tandem aza-wittig/heterocumulene annulation The Journal of Organic Chemistry 70 (24), 10206-10209, 2005
5-) Optimization of a series of dipeptides with a P3 β-neopentyl asparagine residue as non-covalent inhibitors of the chymotrypsin-like activity of human 20S proteasome MedChemComm 3 (6), 710-719, 2012